Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients

Author：

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.3, 2015-01, pp. : 692-698

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radioactive iodine use in patients with low- and intermediate-risk papillary thyroid cancer

By Nixon Iain J Ganly Ian

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 921-923

Future Medicine

Access to resources Recommend Favorite

Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 3, 2013-01 ,pp. : 483-495

Bentham Science Publishers

Access to resources Recommend Favorite

Radioactive iodine in thyroid medicine

By Rasmuson Torgny

Acta Oncologica, Vol. 45, Iss. 8, 2006-12 ,pp. : 1011-1012

Informa Healthcare

Access to resources Recommend Favorite

Radioiodine remnant ablation in low‐risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

Cancer Medicine, Vol. 4, Iss. 7, 2015-07 ,pp. : 1031-1038

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 965-968

Spandidos Publications

Access to resources Recommend Favorite